Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates
- PMID: 10596385
- DOI: 10.1080/01616412.1999.11741010
Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates
Abstract
Critically elevated intracranial pressure (ICP) represents the most important cause of morbidity and mortality in patients suffering from severe traumatic brain injury (TBI) and is a serious complication after subarachnoid hemorrhage (SAH). Thus new strategies for the control of ICP are required. Based on the evidence available hypertonic saline solution (HSS) may be a promising approach. It was therefore the aim of the present study to evaluate in a prospective manner the effects of HSS on ICP and cerebral perfusion pressure (CPP) in patients with therapy-resistant elevation of ICP. A total of 48 bolus infusions of HSS (7.5%, 2 ml kg-1 b.w.; infusion rate 20 ml min-1) were given intravenously (range 1-15 per patient) to 10 patients (age 41 +/- 6 years) with TBI and SAH. Only patients with ICP > 25 mmHg not responding to standard ICP-management protocol and plasma sodium (Na+) concentration < 150 mmol l-1 were included in the study. Within the first hour after HSS application, ICP decreased from 33 +/- 9 mmHg to 19 +/- 6 mmHg (p < 0.05) and further to 18 +/- 5 mmHg at the time of maximum effect (98 +/- 11 min post bolus). Decrease of ICP was accompanied by a rise of CPP from 68 +/- 11 mmHg to 79 +/- 11 mmHg (p < 0.05) after 1 h and further to 81 +/- 11 mmHg at the time of maximum effect. Plasma Na+ concentration was 141 +/- 6 mmol l-1 before and 143 +/- 5 mmol l-1 1 h after HSS bolus. Corresponding values for plasma osmolality were 302 +/- 11 and 308 +/- 12 mOsm l-1. When the ICP lowering effect was transient, subsequent HSS bolus was necessary 163 +/- 54 min after previous dosing. The present results indicate that repeated bolus application of HSS (7.5% NaCl, 2 ml kg-1 b.w.) is an effective measure to decrease ICP which is otherwise refractory to standard therapeutic approaches. Whether or not the therapy scheme is also suited as primary measure for the control of ICP remains to be established.
Similar articles
-
Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure.Crit Care Med. 2008 Mar;36(3):795-800. doi: 10.1097/CCM.0B013E3181643B41. Crit Care Med. 2008. PMID: 18209674 Clinical Trial.
-
A Comparative Study of Bolus Dose of Hypertonic Saline, Mannitol, and Mannitol Plus Glycerol Combination in Patients with Severe Traumatic Brain Injury.World Neurosurg. 2019 May;125:e221-e228. doi: 10.1016/j.wneu.2019.01.051. Epub 2019 Jan 24. World Neurosurg. 2019. PMID: 30684710 Clinical Trial.
-
Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke.Stroke. 1998 Aug;29(8):1550-5. doi: 10.1161/01.str.29.8.1550. Stroke. 1998. PMID: 9707191 Clinical Trial.
-
Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury.Emerg Med J. 2014 Aug;31(8):679-83. doi: 10.1136/emermed-2013-202679. Epub 2013 Jun 28. Emerg Med J. 2014. PMID: 23811861 Review.
-
Evidence for Mannitol as an Effective Agent Against Intracranial Hypertension: An Individual Patient Data Meta-analysis.Neurocrit Care. 2020 Feb;32(1):252-261. doi: 10.1007/s12028-019-00771-y. Neurocrit Care. 2020. PMID: 31264071 Review.
Cited by
-
Hypertonic saline for traumatic brain injury: a systematic review and meta-analysis.Eur J Med Res. 2022 Nov 20;27(1):254. doi: 10.1186/s40001-022-00897-4. Eur J Med Res. 2022. PMID: 36404350 Free PMC article.
-
Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury.Medicine (Baltimore). 2020 Sep 18;99(38):e22004. doi: 10.1097/MD.0000000000022004. Medicine (Baltimore). 2020. PMID: 32957318 Free PMC article. Clinical Trial.
-
Osmotic therapy: fact and fiction.Neurocrit Care. 2004;1(2):219-33. doi: 10.1385/NCC:1:2:219. Neurocrit Care. 2004. PMID: 16174920 Review.
-
Role of hypertonic saline and mannitol in the management of raised intracranial pressure in children: A randomized comparative study.J Pediatr Neurosci. 2010 Jan;5(1):18-21. doi: 10.4103/1817-1745.66673. J Pediatr Neurosci. 2010. PMID: 21042500 Free PMC article.
-
Neuroimaging of traumatic brain injury in military personnel: An overview.J Clin Neurosci. 2019 Dec;70:1-10. doi: 10.1016/j.jocn.2019.07.001. Epub 2019 Jul 19. J Clin Neurosci. 2019. PMID: 31331746 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous